Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 8
1981 5
1982 4
1983 4
1984 1
1985 1
1986 1
1987 1
1988 1
1989 1
1990 1
1992 1
1993 1
1994 3
1995 2
1996 3
1997 2
1998 3
1999 5
2000 2
2001 2
2002 5
2003 3
2004 3
2005 4
2006 3
2007 4
2008 6
2009 6
2010 9
2011 5
2012 3
2013 3
2014 4
2015 4
2016 4
2017 9
2018 9
2019 3
2020 4
2021 5
2022 9
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic.
de Sèze J, Maillart E, Gueguen A, Laplaud DA, Michel L, Thouvenot E, Zephir H, Zimmer L, Biotti D, Liblau R. de Sèze J, et al. Among authors: gueguen a. Front Immunol. 2023 Mar 23;14:1004795. doi: 10.3389/fimmu.2023.1004795. eCollection 2023. Front Immunol. 2023. PMID: 37033984 Free PMC article. Review.
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders.
Ringelstein M, Ayzenberg I, Lindenblatt G, Fischer K, Gahlen A, Novi G, Hayward-Könnecke H, Schippling S, Rommer PS, Kornek B, Zrzavy T, Biotti D, Ciron J, Audoin B, Berthele A, Giglhuber K, Zephir H, Kümpfel T, Berger R, Röther J, Häußler V, Stellmann JP, Whittam D, Jacob A, Kraemer M, Gueguen A, Deschamps R, Bayas A, Hümmert MW, Trebst C, Haarmann A, Jarius S, Wildemann B, Grothe M, Siebert N, Ruprecht K, Paul F, Collongues N, Marignier R, Levy M, Karenfort M, Deppe M, Albrecht P, Hellwig K, Gold R, Hartung HP, Meuth SG, Kleiter I, Aktas O; Neuromyelitis Optica Study Group (NEMOS). Ringelstein M, et al. Among authors: gueguen a. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 16;9(1):e1100. doi: 10.1212/NXI.0000000000001100. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34785575 Free PMC article.
Natalizumab extended-interval dosing in a real-life setting.
Jeantin L, Boudot de la Motte M, Deschamps R, Gueguen A, Gout O, Lecler A, Papeix C, Bensa C. Jeantin L, et al. Among authors: gueguen a. J Neurol Sci. 2023 Jul 15;450:120689. doi: 10.1016/j.jns.2023.120689. Epub 2023 May 13. J Neurol Sci. 2023. PMID: 37210938
Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis.
Leclercq M, Sené T, Chapelon-Abric C, Desbois AC, Domont F, Maillart E, Shor N, Vignal-Clermont C, Guéguen A, Bodaghi B, Cacoub P, Touitou V, Saadoun D. Leclercq M, et al. Among authors: gueguen a. Ocul Immunol Inflamm. 2022 May 19;30(4):821-828. doi: 10.1080/09273948.2020.1834585. Epub 2020 Nov 9. Ocul Immunol Inflamm. 2022. PMID: 33166196
Anti-disialosyl-immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study.
Peillet C, Adams D, Attarian S, Bouhour F, Cauquil C, Cassereau J, Chanson JB, Cintas P, Creange A, Delmont E, Fargeot G, Genestet S, Gueguen A, Kaminsky AL, Kuntzer T, Labeyrie C, Michaud M, Pereon Y, Puma A, Viala K, Chretien P, Adam C, Echaniz-Laguna A. Peillet C, et al. Among authors: gueguen a. Eur J Neurol. 2022 Dec;29(12):3547-3555. doi: 10.1111/ene.15523. Epub 2022 Aug 29. Eur J Neurol. 2022. PMID: 35969369
149 results